CTRI/2024/03/064853
Not Yet Recruiting
N/A
To evaluate the dermatological safety of investigational products through primary irritation patch test on healthy human volunteers with sensitive skin - NI
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ITC LIMITED
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Female and male Asian Indian subjects.
- •2\)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
- •3\)Subjects representing sensitive skin type (Subjects scoring greater than 30 for Section 2\- Sensitive vs Resistant skin in Dr. Baumann’s questionnaire, please refer appendix 4\) and varied skin type (ideally equal representation of all 4 skin types – Oily, Normal, Dry and Combination).
- •4\)For females: Urine pregnancy test (UPT) need to done.
Exclusion Criteria
- •1\)For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.
- •2\) Having eczema, psoriasis, lichen planus, vitiligo etc. in the concerned area.
- •3\)Having healing disorder in the concerned area.
- •4\)Having rhinitis, allergic conjunctivitis, or rhino sinusitis.
- •5\) Having an allergy to perfumes and/or preservatives in cosmetic products.
- •6\)Having an allergy to plaster / adhesives used in plaster.
- •7\) Having a food allergy.
- •8\)Having a cardiovascular pathology that requires beta blocking treatments.
- •9\)Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc.
- •10\)Taking a retinoid\-based treatment by general or oral route.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Safety assessment of test products on skin.CTRI/2022/04/041901ITC LIMITED ITC Life Sciences and Technology Centre23
Completed
N/A
To assess the safety of test products on skiCTRI/2022/02/040014ITC LIMITED ITC Life Sciences and Technology Centre24
Completed
N/A
Checking of safety of productsCTRI/2024/04/065604ITC LIMITED24
Completed
N/A
Safety assessment of test products on skiCTRI/2022/06/043465ITC LIMITED ITC Life Sciences and Technology Centre23
Not Yet Recruiting
N/A
Safety check of products on human volunteersCTRI/2024/07/070779ITC LIMITED